I was wrong about otcjournal (it turned out to be $STAF). We want AMBS to succeed so badly that we make positive connections that don't exist. I am more convinced now that NASDAQ listing at this price (and going lower with unending dilution) is unlikely.

Unless, they might do another reverse split. They can always forward split once listed and with major price appreciation.